Diadema Partners LP

Diadema Partners LP reported 148 holdings worth US$780M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Diadema Partners LP reported 148 holdings worth US$780M as of Sep 30, 2026. Largest: United Therapeutics Corporation, Cogent Biosciences, Inc. and Abivax SA. Filed Nov 16, 2026 (Form 13F).

Holdings
148
Value as reported
US$780M

The filing in full

CompanySharesValue as reported% of portfolio
United Therapeutics Corporation46,222US$25M3.2%
Cogent Biosciences, Inc.642KUS$20.6M2.6%
Abivax SA178KUS$17.7M2.3%
BioMarin Pharmaceutical Inc.255KUS$15.3M2.0%
Revolution Medicines, Inc.70,004US$14.4M1.8%
Viking Therapeutics, Inc.433KUS$14.1M1.8%
BridgeBio Pharma, Inc.104KUS$6.84M0.88%
Immunocore Holdings plc222KUS$6.72M0.86%
4D Molecular Therapeutics, Inc.421KUS$6.03M0.77%
Viridian Therapeutics, Inc.257KUS$5.29M0.68%
Johnson & Johnson17,000US$4.5M0.58%
Indivior Pharmaceuticals, Inc.118KUS$4.21M0.54%
Vaxcyte, Inc.72,850US$4.15M0.53%
Replimune Group, Inc.305KUS$4.04M0.52%
Arcus Biosciences, Inc.154KUS$3.97M0.51%
Kodiak Sciences Inc38,991US$3.7M0.47%
Liquidia Corporation120KUS$3.63M0.47%
MBX Biosciences, Inc.60,000US$3.52M0.45%
Rhythm Pharmaceuticals, Inc.30,000US$2.86M0.37%
Avalo Therapeutics, Inc.182KUS$2.79M0.36%
Corvus Pharmaceuticals, Inc.205KUS$2.36M0.30%
MannKind Corporation604KUS$2.36M0.30%
Insmed Incorporated18,497US$2.11M0.27%
BioCryst Pharmaceuticals, Inc.250KUS$2.08M0.27%
Inventiva SA553KUS$2.06M0.26%
Taysha Gene Therapies, Inc.423KUS$2.06M0.26%
Spruce Biosciences, Inc.40,435US$1.96M0.25%
Edgewise Therapeutics, Inc.44,346US$1.8M0.23%
Pelthos Therapeutics Inc.80,760US$1.7M0.22%
Amylyx Pharmaceuticals, Inc.53,152US$1.55M0.20%
Bicycle Therapeutics PLC399KUS$1.47M0.19%
Relmada Therapeutics, Inc.361KUS$1.36M0.17%
Phathom Pharmaceuticals, Inc.180KUS$1.31M0.17%
Jade Biosciences, Inc.91,259US$1.28M0.16%
Mineralys Therapeutics, Inc.50,000US$1.26M0.16%
Vera Therapeutics, Inc.38,008US$1.23M0.16%
Oruka Therapeutics, Inc.13,169US$1.1M0.14%
MacroGenics, Inc.262KUS$1.01M0.13%
Jasper Therapeutics, Inc.35,271US$874K0.11%
Contineum Therapeutics, Inc.64,549US$866K0.11%
Adial Pharmaceuticals, Inc182KUS$729K0.09%
Summit Therapeutics Inc.41,887US$708K0.09%
NovaBridge Biosciences500KUS$683K0.09%
Quoin Pharmaceuticals. Ltd146KUS$668K0.09%
Kardigan, Inc.43,972US$649K0.08%
Entrada Therapeutics, Inc.100KUS$635K0.08%
Tango Therapeutics, Inc.25,000US$624K0.08%
SELLAS Life Sciences Group, Inc.50,000US$616K0.08%
Larimar Therapeutics, Inc.186KUS$593K0.08%
Silence Therapeutics PLC135KUS$540K0.07%
Nurix Therapeutics, Inc.21,539US$511K0.07%
Fulcrum Therapeutics, Inc.133KUS$494K0.06%
Enliven Therapeutics, Inc.10,000US$458K0.06%
Talphera, Inc.378KUS$439K0.06%
Xenon Pharmaceuticals Inc.10,000US$372K0.05%
Abeona Therapeutics Inc.51,117US$268K0.03%
Ardelyx, Inc.77,133US$264K0.03%
Ocugen, Inc.200KUS$206K0.03%
Attovia Therapeutics, Inc.9,700US$166K0.02%
Heron Therapeutics, Inc.459KUS$144K0.02%
Aytu BioPharma, Inc.67,186US$144K0.02%
JATT II Acquisition Corp12,174US$137K0.02%
Cellectar Biosciences, Inc.71,382US$131K0.02%
Palisade Bio, Inc.69,533US$93,8700.01%
Enanta Pharmaceuticals, Inc.5,503US$72,530<0.01%
Eli Lilly and Company60US$69,425<0.01%
Tvardi Therapeutics, Inc.48,491US$60,614<0.01%
Aprea Therapeutics, Inc.28,872US$21,654<0.01%
Outlook Therapeutics, Inc.35,000US$20,073<0.01%
Elicio Therapeutics, Inc.9,440US$17,181<0.01%
MaxCyte, Inc.8,190US$9,173<0.01%
Intellia Therapeutics, Inc.124US$1,495<0.01%
NextCure, Inc.0US$00.00%
Novo Nordisk A/S Class B0US$00.00%
PepGen Inc.0US$00.00%
Precigen, Inc.0US$00.00%
Relay Therapeutics, Inc.0US$00.00%
Rigel Pharmaceuticals, Inc.0US$00.00%
Spyre Therapeutics, Inc.0US$00.00%
Unicycive Therapeutics, Inc.0US$00.00%
Upstream Bio, Inc.0US$00.00%
Voyager Therapeutics, Inc.0US$00.00%
Xeris Biopharma Holdings, Inc.0US$00.00%
Zymeworks Inc.0US$00.00%
Annexon, Inc.0US$00.00%
ARS Pharmaceuticals, Inc.0US$00.00%
BioAge Labs, Inc.0US$00.00%
Cartesian Therapeutics, Inc.0US$00.00%
Connect Biopharma Holdings Limited0US$00.00%
Corbus Pharmaceuticals Holdings, Inc.0US$00.00%
Cue Biopharma, Inc.0US$00.00%
Cybin, Inc.0US$00.00%
Definium Therapeutics, Inc.0US$00.00%
Equillium, Inc.0US$00.00%
Foghorn Therapeutics Inc.0US$00.00%
Harmony Biosciences Holdings, Inc.0US$00.00%
Kailera Therapeutics, Inc.0US$00.00%
Lakeland Industries, Inc.0US$00.00%
MeiraGTx Holdings plc0US$00.00%
Monopar Therapeutics Inc.0US$00.00%

Every holding of Diadema Partners LP

Source

Download original · View original at SEC

Related